Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01625663 · ClinicalTrials.gov registry record
Heart and Muscle Metabolism in Barth Syndrome
A clinical trial of Barth Syndrome, sponsored by Duke University.
- Completed
- Registry status
- 64
- Enrollment target
- 1
- Study location
NCT01625663 is a study of Barth Syndrome that has completed, run by Duke University. The registered enrollment target is 64 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01625663, a study of Barth Syndrome, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
Barth syndrome (BTHS) is an X-linked disorder caused by abnormal cardiolipin metabolism and is characterized by skeletal and cardiomyopathy and high mortality rates. Through clinical metabolism and imaging studies and pluripotent stem cell induction and molecular techniques on skin biopsy samples, this project will produce novel translational information regarding the pathogenesis of BTHS, reveal potential targets for interventions and provide unique data regarding nutrient metabolism and abnormal cardiolipin and mitochondrial function. This project has the potential to provide information that could significantly improve morbidity and mortality in children and young adults with BTHS and may have relevance to other non-BTHS related conditions such as aging and adult heart failure.
Conditions Studied
Study Locations (1)
Missouri
- Washington University - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2012-06 |
| Est. Completion | 2020-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01625663
The ClinicalTrials.gov registry entry for NCT01625663 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Barth Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT01625663 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT01625663 about?
NCT01625663 is a clinical study titled "Heart and Muscle Metabolism in Barth Syndrome". Barth syndrome (BTHS) is an X-linked disorder caused by abnormal cardiolipin metabolism and is characterized by skeletal and cardiomyopathy and high mortality rates. Through clinical metabolism and imaging studies and pluripotent stem cell induction and molecular techniques on skin biopsy samples, t...
What is the current status of trial NCT01625663?
This trial is currently completed. The enrollment target is 64 participants. The study started on 2012-06. Estimated completion is 2020-03-31.
What conditions does trial NCT01625663 study?
This clinical trial studies the following conditions: Barth Syndrome.
Who is sponsoring clinical trial NCT01625663?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01625663 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Barth Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.